Strong opioids for treatment of chronic pain: A meta-analysis;Stark wirksame opioide zur therapie chronischer schmerzen: Metaanalyse

Schmerz

Volumn 11, Issue 6, 1997, Pages 400-410

  Sorge, Jürgen ^a,c   Werry, Christiane ^b   Pichlmayr, Ina ^b  

^a Krankenhaus des Landkreises Peine

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Krankenhaus des Landkreises Peine   (Germany)

Author keywords

Buprenorphine; Cancer pain; Meta analysis; Methodone; Morphine; Non cancer pain; Strong Opioids; Treatment of chronic pain

Indexed keywords

BUPRENORPHINE; METHADONE; MORPHINE; OPIATE;

ANALGESIA; ANALYTIC METHOD; ARTICLE; CANCER PAIN; CHRONIC PAIN; DRUG EFFECT; GERMANY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031417416     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004820050116     Document Type: Article

References (68)

1. Adams JD, Diehl LF, Wilson JP (1984) Ambulatory use of high-dose intravenous morphine for severe pain. Drug Intell Clin Pharm 18:138-139
2. Arnér S, Meyerson BA (1988) Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33:11-23
3. Bach V, Kamp-Jensen M, Jensen NH, Eriksen J (1991) Buprenorphine and sustained release morphine - effect and side-effects in chronic use. Pain Clinic 4:87-93
4. Baumann TJ, Batenhorst RL, Graves DA, Foster TS, Bennett RL (1986) Patient-controlled analgesia in the terminally ill cancer patient. Drug Intell Clin Pharm 20:297-301
5. Bouckoms AJ, Masand P, Murray GB, Cassem EH, Stern TA, Tesar GE (1992) Chronic nonmalignant pain treated with long-term oral narcotic analgesics. Ann Clin Psychiatry 4:185-192
6. Bruera E, Brenneis C, Michaud M, Chadwick S, MacDonald RN (1987) Continuous sc infusion of narcotics using a portable disposable device in patients with advanced cancer. Cancer Treat Rep 71:635-637
7. Bruera E, Fainsinger R, Spachynski K, Babul N, Harsanyi Z, Darke AC (1995) Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation. J Clin Oncol 13:1520-1527
8. Bruera E, Watanabe S, Fainsinger RL, Spachynski K, Suarez-Almazor M, Inturrisi C (1995) Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain 62:141-146
9. Campbell CF, Mason J, Weiler JM (1983) Continuous subcutaneous infusion of morphine for the pain of terminal malignancy. Ann Intern Med 98:51-52
10. Citron ML, Johnston-Early A, Fossieck BE, Krasnow SH, Franklin R, Spagnolo SV, Cohen MH (1984) Safety and efficacy of continuous intravenous morphine for severe cancer pain. Am J Med 77:199-204
11. Corli O, Roma G, Battaiotto L, Bernoni M (1988) Buprenorphine and diclofenac in cancer pain relief. Schmerz Pain Douleur 9:114-115
12. Crews JC, Sweeney NJ, Denson DD (1994) Clinical efficacy of methadone in patients refractory to other my-opioid receptor agonist analgesics for management of terminal cancer pain. Cancer 72:2266-2272
13. Cundiff D, McCarthy K, Savarese JJ, Kaiko R, Thomas G, Grandy R, Goldenheim P (1989) Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design. Cancer 62:2355-2359
14. De Conno F, Ripamonti C, Sbanotto A, Barletta L, Zecca E, Martini C, Ventafridda V (1991) A clinical study on the use of codeine, oxycodone, dextropropoxyphen, buprenorphine, and pentazocine in cancer pain. J Pain Symptom Manage 7:423-427
15. Dertwinkel R, Wiebalck A, Zenz M, Strumpf M (1996) Orale Opioide zur Langzeittherapie chronischer Nicht-Tumorschmerzen. Anaesthesist 45:495-505
16. Deschamps M, Band PR, Hislop TG, Rusthoven J, Iscoe N, Warr D (1992) The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine. J Pain Symptom Manage 7:384-392
17. Drexel H, Dzien A, Spiegel RW, Lang AH, Breier C, Abbrederis K, Patsch JR, Braunsteiner H (1989) Treatment of severe cancer pain by low-dose continuous subcutaneous morphine. Pain 36:169-176
18. Ferrer-Brechner T, Ganz P (1984) Combination therapy with ibuprofen and methadone for chronic cancer pain. Am J Med 76:78-83
19. Ferrante FM (1996) Principles of opioid pharmacotherapy: practical implications of basis mechanisms. J Pain Symptom Manage 11:265-273
20. Goughnour BR, Arkinstall WW, Stewart JH (1989) Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients. Cancer 63:2294-2297
21. Gralow I, von Hornstein W, Moerchel O, Lawin P (1990) Kontinuierliche subkutane Morphingabe mittels eines externen tragbaren Infusorsystems bei inkurablen Kopf-Hals-Tumoren: Pilotstudie. Eur J Pain 11:147-151
22. Gralow I, von Hornstein W, Schleyer E, Hiddemann W (1995) Kontinuierliche subkutane Buprenorphinapplikation in der Therapie karzinombedingter Schmerzen. Schmerz 9:117-123
23. Grond S, Zech D, Schug SA, Lynch J, Lehmann KA (1991) Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 6:411-422
24. Hanks GW, Twycross RG, Bliss JM (1987) Controlled release morphine tablets: a double-blind trial in patients with advanced cancer. Anaesthesia 42:840-844
25. Hansen J, Ginman C, Hartvig P, Jakobsson PA, Nilsson MI, Rane A, Säwe J, Änggard E (1982) Clinical evaluation of oral methadone in treatment of cancer pain. Acta Anaesthesiol Scand [Suppl] 74:124-127
26. Hotz G (1988) Tumorschmerztherapie im Mund-Kiefer-Gesichtsbereich mit Buprenorphin-Sublingualtabletten. Schmerz 2:38-41
27. Jage J, Jurna I (1993) Opioidanalgetika. In: Zenz M Jurna I (Hrsg) Lehrbuch der Schmerztherapie. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 137-153
28. Kerr IG, Sone M, DeAngelis C, Iscoe N, MacKenzie R, Schueller T (1988) Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients. Ann Intern Med 108:554-557
29. Kim BS, Chung HC (1991) Experience with a controlled-release oral morphine for cancer pain management. Postgrad Med J 67 [Suppl 2]:82-86
30. Koßmann B, Hecht M, Bowdler I, Kilian J, Möller MR (1985) Therapie von Karzinomschmerzen - Vergleich einer wäßrigen Morphinläsung mit MST-Tabletten. Schmerz Pain Douleur 6:143-151
31. Lazarus H, Fitzmartin RD, Goldenheim PD (1990) A multi-investigator clinical evaluation of oral controlled-release morphine (MS Contin Tablets) administered to cancer patients. Hospice J 6:1-15
32. McQuay HJ, Jadad AR, Carroll D, Faura C, Glynn CJ, Moore RA, Liu Y (1992) Opioid sensitivity of chronic pain: a patient-controlled analgesia method. Anaesthesia 47:757-767
33. Melzack R, Mount BM, Goridon JM (1979) The Bromptom mixture versus morphine solution given orally:effects on pain. Can Med Assoc J 120:435-438
34. Mignault GG, Latreille J, Viguié F, Richer P, Lemire F, Harsanyi Z, Stewart JH (1995) Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration. J Pain Symptom Manage 10:416-422
35. Miser AW, Miser JS, Clark BS (1980) Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr 96:930-932
36. Miser AW, Miser JS (1986) The use of oral methadone to control moderate and severe pain in children and young adults with malignancy. Clin J Pain 1:243-248
37. Moran C (1991) MST continus tablets and pain control in severe rheumatoid arthrits. Br J Clin Res 2:1-12
38. Moulin DE, Iezzi A, Amireh R, Sharpe WKJ, Boyd D, Merskey H (1996) Randomized trial of oral morphine for chronic non-cancer pain. Lancet 347:143-147
39. Portenoy RK, Foley KM (1986) Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 25:171-186
40. Portenoy RK, Moulin DE, Rogers A, Inturrisi CE, Foley KM (1986) Iv infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep 70:575-581
41. Portenoy RK, Maldonado M, Fitzmartin R, Kaiko RF, Kanner R (1989) Oral controlled-release morphine sulfate - analgesic efficacy and side effects of a 100-mg tablet in cancer pain patients. Cancer 63:2284-2288
42. Portenoy RK (1996) Opioid therapy for chronic nonmalignant pain: a review of critical issues. J Pain Symptom Manage 11:203-217
43. Rane A, Säwe J, Dahlström B, Paalzow L, Kager L (1982) Pharmacological treatment of cancer pain with special reference to the oral use of morphine. Acta Anaesthesiol Scand [Suppl] 74:97-103
44. Rowbotham MC, Reisner-Keller LA, Fields HL (1991) Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41:1024-1028
45. Schoon W, Erdmann H, Kleeberg UR (1987) Die kontinuierliche subkutane Opioidinfusion in der onkologischen Schmerztherapie. Med Klin 82:805-811
46. Schug SA, Merry AF, Acland RH (1991) Treatment principles for the use of opioids in pain of nonmalignant origin. Drugs 42:228-239
47. Schug SA, Zech D, Grond D, Jung H, Meuser T, Stobbe B (1992) A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage 7:259-266
48. Schulzeck S, Gleim M, Maier C (1993) Morphintabletten bei chronischen nichttumorbedingten Schmerzen - Welche Faktoren beeinflussen Erfolg oder Mißerfolg einer Langzeittherapie? Anaesthesist 42:545-556
49. Sittl R, Richter R (1991) Tumorschmerztherapie bei Kindern und Jugendlichen mit Morphin. Anaesthesist 40:96-99
50. Sorge J, Lehmkuhl C, Lohse K, Herrmann H, Pichlmayr I (1990) Langzeittherapie von Tumorschmerzen mit Morphin-retard-Tabletten. Med Klin 85:523-528
51. Sorge J, Steffmann B, Lehmkuhl C, Pichlmayr I (1991) Opioidanalgetika bei "nichtmalignen" Schmerzen - Langzeitbehandlungsergebnisse bei Patienten mit rheumatischen Beschwerden. Schmerz 5:60-66
52. Strumpf M, Donner B, Zenz M (1995) Morphin-Retardgranulat zur Therapie inkurabler Schmerzen tumorbedingter und nichttumorbedingter Genese - Pilotstudie. Schmerz 9:140-146
53. Stuart GJ, Davey EB, Wight SE (1986) Continuous intravenous morphine infusions for terminal pain control: a retrospective review. Drug Intell Clin Pharm 20:968-972
54. Swanson G, Smith J, Bulich R, New P, Shiftman R (1989) Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients. J Clin Oncol 7:1903-1908
55. Taub A (1982) Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In: Kitahata LM, Collins D (eds) Narcotic analgesics in anesthesiology. Williams & Wilkins, Baltimore, pp 199-208
56. Tennant F, Robinson D, Sagherian A, Seecof R (1988) Chronic opioid treatment of intractable, non-malignant pain. NIDA Res Monogr 81:174-180
57. Urban BJ, France RD, Steinberger EK, Scott DL, Maltbie AA (1986) Long-term use of narcotic/antidepressant medication in the management of phantom limb pain. Pain 24:191-196
58. Ventafridda V, Ripamonti C, Bianchi M, Sbanotto A, De Conno F (1986) A randomized study on oral administration of morphine and methadone in the treatment of cancer pain. J Pain Symptom Manage 1:203-207
59. Ventafridda V, Oliveri E, Caraceni A, Spoldi E, De Conno F, Saita L, Ripamonti C (1987) A retrospective study on the use of oral morphine in cancer pain. J Pain Symptom Manage 2:77-81
60. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F (1987) A validation study of the WHO method for cancer pain relief. Cancer 59:850-856
61. Walsh TD, MacDonald N, Bruera E, Shepard KV, Michaud M, Zanes R (1992) A controlled study of sustained-release morphine sulfate tablets in chronic pain from advanced cancer. Am J Clin Oncol 15:268-272
62. Wan Lu C, Urban B, France RD (1988) Long-term narcotic therapy in chronic pain. Abstract presented at the Canadian and American Pain Societies Joint Meeting, Toronto (Canada), November, 10-13
63. Warfield CA (1989) Evaluation of dosing guidelines for the use of oral controlled-release morphine (MS Contin tablets). Cancer 63:2360-2364
64. World Health Organization (1996) Cancer pain relief: with a guide to opioid availability. WHO, Genf
65. Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 63:55-76
66. Zenz M, Piepen brock S, Tryba M, Glocke M, Everlien M, Klauke W (1985) Langzeittherapie von Krebsschmerzen - Kontrollierte Studie mit Buprenorphin. Dtsch Med Wochenschr 110:448-453
67. Zenz M, Strumpf M, Tryba M, Röhrs E, Steffmann B (1989) Retardiertes Morphin zur Langzeittherapie schwerer Tumorschmerzen. Dtsch Med Wochenschr 114:43-47
68. Zenz M, Strumpf M, Tryba M (1992) Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 7:69-77